Privia Health Q3 Revenue Jumps 32.5%, Net Income Doubles

Ticker: PRVA · Form: 10-Q · Filed: 2025-11-06T00:00:00.000Z

Sentiment: mixed

Topics: Healthcare Services, Physician Enablement, Revenue Growth, Net Income Increase, Accounts Receivable, Market Expansion, 10-Q Analysis

TL;DR

**PRVA's Q3 numbers are solid, but watch that ballooning accounts receivable – it's a red flag for cash flow.**

AI Summary

Privia Health Group, Inc. (PRVA) reported robust financial performance for the three and nine months ended September 30, 2025. Revenue surged to $580.4 million for the three months, a 32.5% increase from $437.9 million in the prior year, and reached $1.58 billion for the nine months, up 24.0% from $1.28 billion. Net income attributable to Privia Health Group, Inc. stockholders more than doubled to $6.86 million for the quarter, compared to $3.54 million in 2024, and increased to $13.77 million for the nine-month period, up from $9.99 million. Operating expenses also rose, with provider expense hitting $455.2 million for the quarter and $1.24 billion for the nine months, reflecting increased scale. The company expanded its operations into two new markets, Indiana and Arizona, bringing its total to sixteen markets. Cash and cash equivalents decreased by $49.8 million to $441.35 million, primarily due to $89.06 million in business acquisitions, net of cash acquired, for the nine months ended September 30, 2025. Accounts receivable significantly increased to $499.04 million from $316.18 million at December 31, 2024, indicating higher revenue recognition or slower collections.

Why It Matters

Privia Health's strong revenue and net income growth signal effective execution of its physician-enablement strategy, which is crucial for investors looking for scalable healthcare models. The expansion into Indiana and Arizona demonstrates continued market penetration, potentially increasing its competitive footprint against rivals like Optum and Aledade. For employees and Privia Providers, this growth suggests stability and opportunities within an expanding network. Customers benefit from a broader reach of integrated care. However, the significant increase in accounts receivable warrants investor scrutiny, as it could impact future cash flow and operational efficiency if not managed effectively in a competitive healthcare landscape.

Risk Assessment

Risk Level: medium — The risk level is medium due to the substantial increase in accounts receivable, which jumped from $316.18 million at December 31, 2024, to $499.04 million at September 30, 2025. This 57.8% increase could signal potential collection issues or aggressive revenue recognition, impacting future liquidity. Additionally, the company's cash and cash equivalents decreased by $49.8 million, partly due to $89.06 million in business acquisitions, indicating significant capital deployment for growth.

Analyst Insight

Investors should monitor PRVA's upcoming earnings calls for detailed explanations regarding the substantial increase in accounts receivable and its impact on cash conversion cycles. While growth is strong, a deeper dive into the quality of earnings and cash flow generation is warranted before making further investment decisions. Consider if the acquisition strategy is generating sufficient returns to offset the cash outflow.

Financial Highlights

debt To Equity
N/A
revenue
$580.4M
operating Margin
2.48%
total Assets
$1.35B
total Debt
N/A
net Income
$6.86M
eps
N/A
gross Margin
N/A
cash Position
$441.35M
revenue Growth
+32.5%

Revenue Breakdown

SegmentRevenueGrowth
Total Revenue$580.4M+32.5%
Total Revenue (YTD)$1.58B+24.0%

Key Numbers

Key Players & Entities

FAQ

What were Privia Health Group, Inc.'s revenues for the third quarter of 2025?

Privia Health Group, Inc. reported revenues of $580.4 million for the three months ended September 30, 2025. This represents a significant increase from $437.9 million reported in the same period of 2024.

How did Privia Health's net income change in Q3 2025 compared to the previous year?

Net income attributable to Privia Health Group, Inc. stockholders more than doubled to $6.86 million for the three months ended September 30, 2025, up from $3.54 million in the prior year's third quarter.

What is the current status of Privia Health's accounts receivable?

As of September 30, 2025, Privia Health's accounts receivable stood at $499.04 million. This is a substantial increase from $316.18 million reported at December 31, 2024.

How many markets does Privia Health operate in as of September 30, 2025?

As of September 30, 2025, Privia Health operates in sixteen markets, including recent expansions into Indiana and Arizona. This demonstrates continued geographic growth for the company.

What were the cash and cash equivalents for Privia Health at the end of Q3 2025?

Privia Health reported cash and cash equivalents of $441.35 million at September 30, 2025. This is a decrease from $491.15 million at the beginning of the period.

What is the primary risk highlighted by the increase in Privia Health's accounts receivable?

The primary risk highlighted by the 57.8% increase in accounts receivable is potential pressure on future cash flow and liquidity. A large and growing accounts receivable balance can indicate slower collections or aggressive revenue recognition, which could impact the company's ability to fund operations or future investments.

What is Privia Health's strategy for growth, as indicated in the filing?

Privia Health's growth strategy involves expanding into new geographic markets and organizing physicians into a unique practice model that combines large regional medical groups with provider autonomy. The company expanded into Indiana and Arizona during the period.

How much did Privia Health spend on business acquisitions in the first nine months of 2025?

For the nine months ended September 30, 2025, Privia Health used $89.06 million for business acquisitions, net of cash acquired. This indicates a significant investment in expanding its operational footprint.

What is a 'Medical Group' in the context of Privia Health's operations?

A 'Medical Group' refers to a partnership of existing physicians and non-physician clinicians organized by Privia Health in a specific market. These groups combine the advantages of a large regional medical group with significant provider autonomy for its members.

What should investors consider regarding Privia Health's stock-based compensation expense?

Investors should note that stock-based compensation expense for the nine months ended September 30, 2025, was $55.62 million, an increase from $41.40 million in the prior year. While a non-cash expense, it impacts diluted earnings per share and can signal dilution for existing shareholders.

Risk Factors

Industry Context

The healthcare services sector, particularly value-based care and physician enablement platforms, is experiencing rapid growth driven by the shift towards outcome-based reimbursement models. Companies like Privia Health are expanding their reach to capture market share and integrate more providers into their networks. Competition is intensifying as both established players and new entrants vie for provider partnerships and patient populations.

Regulatory Implications

Privia Health operates in a highly regulated industry. Changes in healthcare policy, reimbursement rates from government programs like Medicare and Medicaid, and compliance with HIPAA are critical. Expansion into new markets requires navigating varying state-specific regulations. Any missteps in compliance or adverse regulatory changes could significantly impact financial performance.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Provider expense
Costs incurred for services provided by physicians and other healthcare professionals contracted by Privia Health. (A major operating expense for Privia, directly tied to the volume of services rendered and the company's scale.)
Non-controlling interest
The portion of equity in a subsidiary that is not attributable to the parent company. In this case, it represents the ownership stake not held by Privia Health Group, Inc. stockholders. (Indicates that Privia operates with partially owned subsidiaries, and their net income is separated from the parent company's net income.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Significant increase in goodwill suggests recent acquisitions, which are a key growth strategy for Privia but also carry integration and valuation risks.)
Operating right-of-use asset
An asset recognized under accounting standards for leases, representing the lessee's right to use an underlying asset for the lease term. (Reflects the company's use of leased facilities or equipment, impacting operating expenses and balance sheet.)
Provider liability
Obligations owed to healthcare providers for services rendered but not yet paid. (A significant current liability that has grown substantially, indicating increased service volume or changes in payment terms.)

Year-Over-Year Comparison

Compared to the prior year, Privia Health Group, Inc. has demonstrated strong top-line growth, with Q3 revenue up 32.5% and year-to-date revenue up 24.0%. Net income attributable to stockholders has also seen substantial improvement, more than doubling in the quarter. However, the balance sheet shows a significant increase in accounts receivable (57.8%) and a decrease in cash, largely due to substantial investments in business acquisitions. Operating expenses, particularly provider expense, have also risen considerably, reflecting the company's expanding scale.

Filing Stats: 4,442 words · 18 min read · ~15 pages · Grade level 19.4 · Accepted 2025-11-06 08:45:50

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1. Condensed Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets 2 Condensed Consolidated Statements of Operations 3 Condensed Consolidated Statements of Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 28 Item 4.

Controls and Procedures

Controls and Procedures 28

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 28 Item 1A.

Risk Factors

Risk Factors 29 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29 Item 3. Defaults Upon Senior Securities 29 Item 4. Mine Safety Disclosures 29 Item 5. Other Information 29 Item 6. Exhibits 30

Signatures

Signatures 31 Table of Contents INFORMATION REGARDING FORWARD-LOOKING STATEMENTS This quarterly report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "could," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "seeks" or "continue," the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include factors related to, among other things: the heavily regulated industry in which we operate, and any failure by us or our Medical Groups (defined herein) to comply with the extensive applicable healthcare laws and government regulations, as in effect from time to time, could result in adverse financial impacts, require us to make significant changes to our operations or cause us to experience reputational harm; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia Providers (each, defined herein), and the impact of legal challenges

- Financial Information

Part I - Financial Information

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Privia Health Group, Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share amounts) September 30, 2025 December 31, 2024 Assets (unaudited) Current assets: Cash and cash equivalents $ 441,352 $ 491,149 Accounts receivable 499,041 316,179 Prepaid expenses and other current assets 30,533 27,495 Total current assets 970,926 834,823 Non-current assets: Property and equipment, net 662 1,242 Operating right-of-use asset 5,671 4,828 Intangible assets, net 167,539 109,807 Goodwill 172,215 141,615 Deferred tax asset 17,046 26,383 Other non-current assets 16,928 17,085 Total non-current assets 380,061 300,960 Total assets $ 1,350,987 $ 1,135,783 Liabilities and stockholders' equity Current liabilities: Accounts payable and accrued expenses $ 84,668 $ 81,986 Provider liability 495,683 364,607 Operating lease liabilities, current 2,563 2,553 Total current liabilities 582,914 449,146 Non-current liabilities: Operating lease liabilities, non-current 3,672 3,037 Other non-current liabilities 1,640 153 Total non-current liabilities 5,312 3,190 Total liabilities 588,226 452,336 Commitments and contingencies (Note 10) Stockholders' equity: Common stock, $ 0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 122,867,531 and 120,309,346 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 1,229 1,203 Additional paid-in capital 873,356 813,209 Accumulated deficit ( 165,461 ) ( 179,229 ) Total Privia Health Group, Inc. stockholders' equity 709,124 635,183 Non-controlling interest 53,637 48,264 Total stockholders' equity 762,761 683,447 Total liabilities and stockholders' equity $ 1,350,987 $ 1,135,783 The accompanying notes are an integral part of these condensed consolidated financial statements. 2 Table of Contents Privia Health Group, Inc. Condensed Consolidated Statements of Operations (unaudited) (in thousands, except

View on Read The Filing